I am an Imperial College Research Fellow at the MRC Centre for Global Infectious Disease Analysis. I work on mathematical models of infectious diseases, focussed on childhood diseases and the public health impact of new vaccines.
The main focus of my current research is to develop dynamic models for respiratory synctial virus (RSV) transmission and vaccination, to inform target product profiles for RSV vaccine in low-income settings.
I also work on a range of other projects related to estimating the public health impact of the RTS,S/AS01 malaria vaccine and second-generation malaria vaccines in malaria endemic areas.
Before joining the Department of Infectious Disease Epidemiology at Imperial College London, I completed my PhD program at the Research School of Population Health at the Australian National University.
A full list of publications is at www.alexandrahogan.com.
et al., 2021, Interpreting estimates of coronavirus disease 2019 (COVID-19) vaccine efficacy and effectiveness to inform simulation studies of vaccine impact: a systematic review, Wellcome Open Research, Vol:6, Pages:185-185
et al., 2021, Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand, Vaccine, ISSN:0264-410X, Pages:4383-4390
et al., 2021, Health inequities and clustering of fever, acute respiratory infection, diarrhoea and wasting in children under five in low- and middle-income countries: a Demographic and Health Surveys analysis, Bmc Medicine, Vol:19, ISSN:1741-7015
et al., 2021, A systematic review of the costs relating to non-pharmaceutical interventions against infectious disease outbreaks, Applied Health Economics and Health Policy, ISSN:1175-5652
et al., 2021, Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: a mathematical modelling analysis, Vaccine, Vol:39, ISSN:0264-410X, Pages:2995-3006